eXoZymes, Inc. (EXOZ) vs Microbot Medical Inc. (MBOT)
A side-by-side comparison of eXoZymes, Inc. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EXOZ
eXoZymes, Inc.
$5.54HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
MBOT
Microbot Medical Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — EXOZ vs MBOT
growth of $100 · dividends reinvested · last 2yEXOZ -36.2% (-20.1%/yr)MBOT +5.9% (+2.9%/yr)MBOT compounded faster over this window
EXOZ MBOT
EXOZ vs MBOT: by the numbers
- •EXOZ is the larger company ($51M vs $50M market cap).
- •Both run net losses; EXOZ's is the smaller (0.00% vs -4722.25% net margin).
Metrics side by side
Valuation
| Metric | EXOZ | MBOT |
|---|---|---|
| P/S ratio | N/A | 145.54 |
| P/B ratio | 14.07 | 0.73 |
Profitability
| Metric | EXOZ | MBOT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -4722.25% |
| ROE | -278.89% | -23.70% |
| ROIC | -157.40% | -26.51% |
Growth (annualized)
| Metric | EXOZ | MBOT |
|---|---|---|
| Total return CAGR (5Y) | N/A | -31.63% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.